NNI:NYSENelnet, Inc. Analysis
Data as of 2026-06-06 - not real-time
$129.03
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Nelnet, Inc. (NNI) is trading at $129.03, just below its 20‑day SMA of 127.47 and well under the 50‑day SMA of 132.71, with the price hovering between the computed support of $116.62 and resistance of $132.22. The RSI of 45.7 and a bullish MACD histogram (+0.26) suggest a neutral‑to‑slightly positive short‑term momentum, while volume trends are decreasing, adding a note of caution. Valuation metrics are attractive: the trailing P/E of 11.22 is markedly below the industry average of 17.0, and the price‑to‑book of 1.24 indicates the stock is trading close to its book value. Dividend sustainability looks solid, with a 1% yield supported by a modest 10.8% payout ratio and strong cash flow generation.
Fundamentally, the company posted a 7.1% year‑over‑year revenue decline to $1.65 billion, yet maintains impressive gross (86.6%) and operating (21.4%) margins. Earnings per share missed consensus, with non‑GAAP EPS of $1.94 falling 27% short of expectations, highlighting near‑term earnings pressure. The balance sheet is heavily leveraged, reflected by a debt‑to‑equity of over 213, but the low beta (≈0.46) and a 30‑day volatility of 44.5% suggest market risk is moderated. Overall, NNI appears undervalued with a reliable dividend, but faces earnings and leverage headwinds.
Fundamentally, the company posted a 7.1% year‑over‑year revenue decline to $1.65 billion, yet maintains impressive gross (86.6%) and operating (21.4%) margins. Earnings per share missed consensus, with non‑GAAP EPS of $1.94 falling 27% short of expectations, highlighting near‑term earnings pressure. The balance sheet is heavily leveraged, reflected by a debt‑to‑equity of over 213, but the low beta (≈0.46) and a 30‑day volatility of 44.5% suggest market risk is moderated. Overall, NNI appears undervalued with a reliable dividend, but faces earnings and leverage headwinds.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Neutral technical stance with price near support and resistance
- Recent earnings miss and decreasing volume
- Attractive valuation but high leverage
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Undervalued metrics versus industry peers
- Strong dividend yield and low payout ratio
- Persistent revenue decline and elevated debt levels
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Low P/E and P/B relative to sector suggest upside potential
- Sustainable dividend provides income cushion
- Stable cash flow generation despite leverage
Key Metrics & Analysis
Financial Health
Revenue Growth-7.10%
Profit Margin25.34%
P/E Ratio11.2
ROE10.70%
ROA2.63%
Debt/Equity213.54
P/B Ratio1.2
Op. Cash Flow$404.9M
Industry P/E17.0
Technical Analysis
TrendNeutral
RSI45.7
Support$116.62
Resistance$132.22
MA 20$127.47
MA 50$132.71
MA 200$130.92
MACDBullish
VolumeDecreasing
Fear & Greed Index83.02
Valuation
Target Price$135.00
Upside/Downside4.63%
GradeUndervalued
TypeValue
Dividend Yield1.00%
Risk Assessment
Beta0.46
Volatility44.52%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.